Página 11 - Melhores TC (tomografia computadorizada) médicos - TOP-487 médicos

Specializations

Adult and Pediatric Trauma Surgery

Knee, Shoulder, Ankle Arthroscopic Surgery

Knee Prosthesis, Hip Prosthesis, Shoulder Prosthesis

Deformity and Lengthening Surgery

Sports Surgery

General information

Musculoskeletal radiologist, expert in sports injuries and magnetic resonance imaging with over 20 years of experience working with professional and elite athletes.

Professional experience

• Founder : Elite Sports Imaging, SL, Madrid, Spain.
• Medical consultant : Madrid Open (tennis tournament).
• Consultant : Longwood MRI Specialists, Boston, USA.
• Director of Musculoskeletal MRI and CT : Massachusetts General Hospital/Harvard Medical School (2002–2006).

Education and qualifications

• University of California, Los Angeles (UCLA) : Bachelor of Science in Kinesiology and Exercise Science (BS).
• McGill University School of Medicine : Doctor of Medicine and Master of Surgery (MD, CM).
• Boston University/Boston Medical Center : Radiology Residency.
• Harvard Medical School/Massachusetts General Hospital : Fellowship in Musculoskeletal Radiology and Interventional Radiology.
• Massachusetts Institute of Technology (MIT)/m+Visión : Postdoctoral Fellowship in Biomedical Research in Medical Imaging.

Peculiarities of professional activity

The doctor specializes in:

• Diagnosis and treatment of sports injuries using MRI and CT.
• Implementation of advanced technologies in the field of visualization of the musculoskeletal system.
• A personalized approach to diagnosing injuries in elite athletes.

The doctor has exceptional experience working at leading global institutions such as Harvard Medical School and MIT, which allows him to combine clinical practice, scientific research and the application of innovative methods in medical imaging.

Assoc. Prof. Dr. Burak Eren
Specialist in Brain and Nerve Surgery

Neurosurgery Areas of Interest
    •    Brain Tumors
    •    Pituitary Tumors (Endoscopic)
    •    Brain Aneurysms
    •    Skull Base Tumors
    •    Spinal and Spinal Cord Tumors
    •    Lumbar Disc Herniation
    •    Cervical Disc Herniation
    •    Spondylolisthesis
    •    Spinal Canal Stenosis
    •    Traumatic Brain and Spinal Injuries

Personal Information
    •    Date of Birth: 03/11/1979
    •    Marital Status: Married, Father of 2 children
    •    Languages: English
    •    Title: Associate Professor – 10/03/2021

Education
    •    Bachelor’s Degree: Eskişehir Osmangazi University Faculty of Medicine, 1997-2003
    •    Specialty Training: Bezmi Alem Valide Sultan Education and Research Hospital, Neurosurgery Clinic / Istanbul, 2004-2010

Professional Experience
    •    Köyceğiz SSK Dispensary / Muğla (2003-2004)
    •    Bezmi Alem Valide Sultan Education and Research Hospital / Istanbul (2004-2010)
    •    Bakırköy Dr. Sadi Konuk Education and Research Hospital / Istanbul (2010-2012)
    •    Bilecik State Hospital / Bilecik (2012-2013)
    •    Special Nisa Hospital / Istanbul (2013-2014)
    •    Bağcılar Education and Research Hospital / Istanbul (2014-2024)

Articles Published in International Peer-Reviewed Journals:
    1.    Sağlam-Çifci Ece, Güleç İlker, Şengelen Aslıhan, Karagöz-Güzey Feyza, EREN BURAK, Paşaoğlu H Esra, Önay-Uçar Evren. The H4R antagonist, JNJ-7777120 treatments ameliorate mild traumatic brain injury by reducing oxidative damage, inflammatory and apoptotic responses through blockage of the ERK1/2/NF-κB pathway in a rat model (2025). Experimental Neurology. 115133. DOI: 10.1016/j.expneurol.2024.115133.
    2.    EREN BURAK, Karagoz Guzey Feyza, Gulec Ilker, Tufan Azmi, Bas Nuri Serdar. The Importance of Spinopelvic Parameters in Recurrent Lumbar Disk Herniation. Clinical Spine Surgery, 37(3), E113-E118. (2024). DOI: 10.1097/BSD.0000000000001546.
    3.    Aycan Abdurrahman, EREN BURAK, Tas Abdurrahim. Treatment and outcomes of patients with metastatic spinal cord compression: a double-center study. European Review for Medical and Pharmacological Sciences, 27(13), 6121-6131. (2023). DOI: 10.26355/eurrev_202307_32968.
    4.    Yücel Murat, Aktaş Özgür Yusuf, Zengi Oğuzhan, Taş Abdurrahim, Tufan Azmi, EREN BURAK, Karagöz Güzey Feyza. The effect of alpha-lipoic acid on nerve tissue healing after sciatic nerve crush injury in rats. Annals of Medical Research, 30(6), 684-691. (2023). DOI: 10.5455/annalsmedres.2023.09.246.
    5.    Tufan Azmi, Aktaş Özgür, EREN BURAK, Doruk Ebru, Gulec Ilker, Taş Abdurrahim, Karagoz Guzey Feyza. Effects of Age and Co-Morbidities on Complication Rate in Surgical Treatment of Lumbar Degenerative Diseases: A Prospective Clinical Study. Eastern Journal of Medicine, 28(4). (2023). DOI: 10.5505/ejm.2023.89646.

Papers Presented at International Scientific Conferences:
    1.    EREN BURAK. Comparison of Patients Who Voluntarily Applied to the Neurosurgery Outpatient Clinic Due to Spinal Diseases and Patients Referred by Family Physicians. 19th International Eastern Mediterranean Family Medicine Congress, 1266-1267. (2020). (Abstract/Oral Presentation) (Publication No: 6514176).
    2.    EREN BURAK. Relationship Between Spinopelvic Parameters and Recurrent Lumbar Disc Herniation. World Spinal Column Society Virtual World Spine. (2020). (Abstract/Oral Presentation) (Publication No: 6514209).
    3.    Tas Abdurrahim, Karagoz Guzey Feyza, Tufan Azmi, Kuvat Nuray, Aktaş Özgür Yusuf, EREN BURAK, Yücel Murat, Kahraman Akkalp Asli. Prophylactic Effects of Silver Nanoparticles in a Rat Model of Spinal Stabilization and Infection. World Federation of Neurosurgical Societies XVI. World Congress, 33-34. (2017). (Abstract/Oral Presentation) (Publication No: 6513245).

Chapters in Scientific Books:
    1.    Klinik Nöroanatomi (Clinical Neuroanatomy), Chapter Title: (Lesions of the Hypophysis and Hypothalamus, Their Pathophysiology, and Surgical Anatomy) (2023). EREN BURAK, Tufan Azmi. Güneş Tıp Kitabevleri. Editors: Karagöz Güzey Feyza, Balcıoğlu Hüseyin Avni. 1st Edition. Page Count: 613. ISBN: 978-975-277-971-6. (Scientific Book in Turkish).
    2.    Nöroşirürjinin Temelleri (Fundamentals of Neurosurgery), Chapter Title: (Diagnosis, Classification, and Treatment of Thoracolumbar and Sacral Trauma) (2020). EREN BURAK, Karagöz Guzey Feyza. US Akademi. Editors: Naderi Sait, Karagöz Güzey Feyza, Tuğcu Bekir. 1st Edition. Page Count: 610. ISBN: 978-605-9358-. (Scientific Book in Turkish).

Articles Published in National Peer-Reviewed Journals:
    1.    EREN BURAK, Karagöz Güzey Feyza, Güleç İlker, Baş N. Serdar, Ay Ferhat, Acaroğlu Muhammed A., Çuhacıbaşı Enes B. Neurosurgery Career Preferences Compared to Other Medical Specialties among Turkish Students. Tıp Eğitimi Dünyası, 22(68), 143-153.
    2.    EREN BURAK, Gulec Ilker, Karagoz Guzey Feyza, Saglam Ece, Tufan Azmi, Karacan Murat, Bas Nuri Serdar. Evaluation of Multiple Myeloma Patients Undergoing Decompression Due to Spinal Cord Pressure. Osmangazi Journal of Medicine, 42(5), 546-552. (2020). DOI: 10.20515/otd.571004.

Technical Notes, Case Reports, Research Notes, etc.:
    1.    Case Report: EREN BURAK, Karagoz Guzey Feyza, Gulec Ilker. Craniopharyngioma and Arteriovenous Malformation Operated Using the Same Craniotomy: An Unusual Case. Romanian Neurosurgery, 34(3), 437-440. (2020). DOI: 10.33962/roneuro-2020-070.
    2.    Case Report: Tufan Azmi, EREN BURAK, Tas Abdurrahim, Berker Neslihan, Aktaş Özgür Yusuf, Gulec Ilker, Vatansever Mustafa Safi, Karacan Murat, Vahabova Günay, Karagoz Guzey Feyza. Spinal Metastasis as a Presenting Feature of Follicular Type Thyroid Carcinoma: A Case Report and Review of the Literature. Bagcilar Medical Bulletin, 4(1), 1-9. (2019). DOI: 10.4274/BMB.galenos.2019.26888.

Education & Expertise

• 2001 | Istanbul University Cerrahpaşa Faculty of Medicine – Medical Education
• 2001 to 2005 | Maltepe University Faculty of Medicine, Department of Cardiology – Research Assistant
• 2010 to 2018 | Kartal Koşuyolu Yüksek İhtisas Training and Research Hospital – Cardiology Specialist, Chief Assistant
• 2014 | Associate Professorship, Kartal Koşuyolu High Specialization Training and Research Hospital

Professional Experience

• 2001 to 2005 | Maltepe University Faculty of Medicine, Department of Cardiology – Research Assistant
• 2006 to 2007 | Kayseri Military Hospital – Cardiologist
• 2007 to 2010 | Kartal Yavuz Selim State Hospital – Cardiologist
• 2010 to 2018 | Kartal Koşuyolu Yüksek İhtisas Training and Research Hospital – Cardiologist, Chief Assistant

Professional Memberships

• -Istanbul Medical Chamber
• -Turkish Cardiology Association
• -Chronic Total Occlusion Club

Education & Expertise

1994 | Hacettepe University Faculty of Medicine

2002 | Marmara University Faculty of Medicine – PhD in Orthopedics and Traumatology

Professional Experience

1997 to 2002 | Marmara University, Orthopedics and Traumatology Department – Research Assistant

2002 to 2005 | Marmara University, Orthopedics and Traumatology – Specialist Doctor

2005 to 2010 | Marmara University, Orthopedics and Traumatology Department – Assistant Professor

2010 to 2016 | Marmara University, Orthopedics and Traumatology – Associate Professor

2016 to 2018 | Marmara University, Orthopedics and Traumatology – Professor

Foreign Experience

2001 to 2002 | Children’s Hospital of Philadelphia – Research Clinical Fellow in Orthopedics and Traumatology

July to August 2012 | The Royal Orthopaedic Hospital – Clinical Visitor in Orthopedic Oncology

Professional Memberships

-Turkish Orthopaedics and Traumatology Association

-Turkish Orthopaedics and Traumatology Association – Pediatric Orthopaedics -Branch

-Turkish Orthopaedics and Traumatology Association – Orthopaedic Oncology Branch

-European Pediatric Orthopaedics Society

Awards & Recognitions

2001 | Akif Şakir Şakar Scientific Award – Second Prize in Experimental Study

2004 | IX. Akif Şakir Şakar Scientific Awards – Second Prize in Experimental Study

2007 | XII. Akif Şakir Şakar Science Awards – Second Place in Clinical Study Category

2007 | Derviş Manizade Awards – Second Place

2014 | XXIV. National Turkish Orthopedics and Traumatology Congress – First Prize in Orthopedic Oncology Oral Presentation

Prof. Dr. Ozan Beytemur is an experienced orthopedic surgeon with over 20 years in the field. He is a Professor at Health Sciences University, Istanbul Bağcılar Health Practice and Research Center. He is known for his research in bone healing, osteoporosis prediction, and orthopedic biomechanics. He has published many articles in leading international journals.

Dr. Beytemur has served as Chief Physician and has led improvements in orthopedic care and education. He holds the TOTBİD-TOTEK Board Certification. He has also completed international courses, including the AO Pediatric Trauma Course. He specializes in complex surgeries, such as bone tumor treatment and advanced fracture management. He is active in Turkish orthopedic associations and has supervised important theses, helping to advance orthopedic science and education.

EDUCATION:

• Turhan and Mediha Tansel Primary School (1979–1984)
• Kültür College (1984–1988)
• Semiha Şakir High School (1988–1991)
• Marmara University Faculty of Medicine (1991–1997)
• Marmara University Faculty of Medicine, Neurosurgery Department, Specialist Training (1997–2002)
• Title of Associate Professor in Neurosurgery (May 31, 2021)

ADDITIONAL TRAINING:

• "Visiting Physician," University of Southern California, Department of Neurosurgery (1998)
• "Microsurgery Training," GATA (Gülhane Military Medical Academy), Ankara Education and Research Hospital (2003)

PROFESSIONAL EXPERIENCE:

• Gülhane Military Medical Academy Haydarpaşa Training and Research Hospital (2002–2003)
• Dr. Lütfi Kırdar Kartal Training and Research Hospital (2003–2005)
• Private Avicenna Ataşehir Hospital (2005–2012)
• Private 29 Mayıs Hospital (2012–2013)
• Maltepe State Hospital (2013–2018)
• Kartal Dr. Lütfi Kırdar City Hospital (2018–2020)
• Private Academic Hospital (2020–2022)
• Hisar Intercontinental Hospital (2022–2024)
• Private Medipol Acıbadem Regional Hospital (2024–Present)

ADMINISTRATIVE AND ACADEMIC ROLES:

• Board Member, Neurosurgical Society (2006–2009)
• Head of the Emergency Department, Maltepe State Hospital (2014–2016)
• Deputy Chief Physician, Private Academic Hospital (2020–2021)
• Advisory Board Member, Beykent University Faculty of Medicine (2018–2024)
• Faculty Member, Galata University Faculty of Health Sciences (2022–2024)
• Director, Continuous Education Center, Galata University (2022–2024)

Education and Expertise

BAŞKENT UNIVERSITY FACULTY OF MEDICINE

diseases

Heart failure

Valve Diseases

Heart Holes

Cardiovascular Occlusion

Aortic Vein Aneurysm

Cardio Oncology

Resistant Hypertension

Rhythm Disorders

Treatment Methods

Pacemaker Applications

Mitraclip

triclip

TAVI Application

Closing Heart Holes

Balloon Stent

Stent Application to Aortic Aneurysms

Heart checks for oncology patients

In Resistant Hypertension patients

Ablation application Renal Denervation

Cryotherapy Application

Experience

2005 – 2010 Başkent University Faculty of Medicine – Specialization

2010 – Cleveland Clinic Interventional Cardiology Training

Professional Memberships

Turkish Society of Cardiology

Turkish Medical Association

European Society of Cardiology (ESC)

European Association of Cardiovascular Imaging (EAVI)

Personal Information

Name Surname: İbrahim COŞKUNER

Birthplace - Year: 1964

Academic Title: Op. Dr.

Foreign Language: English

Education

Karadeniz University Faculty of Medicine

SB Ankara Hospital

Work Experience

Bursa City Hospital 2020

Artvin State Hospital 2005

Osteoarthritis Treatment; Intra-articular Botox Application

Treatment of Nonunion Fractures with new generation Composite Implants

Use of Composite Implants in early Fracture Healing

Joint Replacement in Hip and Knee Arthritis; Replacement of Joint with Prosthesis - Quality Metal Implants

Stem Cell Applications in Developmental Disorders

Knee Ligament Injury Repair Reconstructive Interventions

Spine Curvature Treatment Surgical Intervention

Ilizarov System Applications Surgical Treatment of Open Fractures, Correction of Deformities

Trauma to the bone structures

Knee Surgery

Structural Bone Disorders

Hand Surgery Athlete Traumatology

Pediatric Surgery

Intra-Articular Injections

PRP Injection

Anterior Cruciate Ligament Surgery

Neurologist

Dr. Hodaya Cohen is a board-certified Obstetrician and Gynecologist at Hadassah Medical Center. She is known for her skill in handling complex cases and providing advanced care for women.

Dr. Cohen has performed more than 1,500 procedures. She has also contributed to several clinical studies. She is accredited by top medical boards. Dr. Cohen is dedicated to evidence-based medicine and puts her patients first.

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Experience

2018

Private Istanbul Medipol Hospital

2018

Medipol University Camlica Hospital

2018

Medipol Camlica Hospital

2013 - 2018

Medipol Mega University Hospital

2011 - 2013

Yuzuncu Yil University Hospital

2010 - 2011

Gulhane Military Medical Academy

2010 - 2013

Yuzuncu Yil University Hospital

2010 - 2011

Gulhane Military Medical Academy

2010 - 2011

Gulhane Military Medical Academy

2010 - 2013

Yuzuncu Yil University Faculty of Medicine

2009

University of Toronto SickKids Hospital

2004 - 2008

Private Van-Etfal Pediatric Diseases

1999 - 2004

Yuzuncu Yil University Hospital

Education

2010

Yuzuncu Yil University, Pediatric Nephrology

2004

Yuzuncu Yil University, Pediatrics

1998

Ege University, Faculty of Medicine

Experience

2019 - 2022 Medipol University

2010 Private Nisa Hospital

2008 - 2010 Kaman State Hospital

Education

2008

Istanbul University Cerrahpaşa Faculty of Medicine, Obstetrics and Gynecology

2002

Istanbul University, Istanbul Faculty of Medicine

Experience

2018 - 2022

Health Sciences University – Şişli Hamidiye Etfal Training and Research Hospital

2016 - 2018

Diyarbakır Memorial Dicle Hospital Cardiology Clinic

2010 - 2010

Dicle University Faculty of Medicine, Department of Cardiology

2010 - 2016

Private Veni Vidi Hospital, Cardiology Clinic Supervisor

2006 - 2010

Dicle University Faculty of Medicine, Department of Cardiology

2005 - 2006

Urfa State Hospital

1999 - 2005

Turkey High Specialization Training and Research Hospital

1998 - 1999

Duruca Health Center

Education

2018

Health Sciences University, Cardiology

2010

Dicle University, Department of Cardiology

2005

Cardiology Turkey High Specialization Training and Research Hospital, Medical Specialization

1998

Ege University, Faculty of Medicine

Dr. Walter Klepetko is a Professor and Head of the Division of Thoracic Surgery at MedUni Vienna and Vienna General Hospital. He is an expert in thoracic surgery, lung transplantation, surgery for bronchial carcinoma, and pulmonary hypertension.

He founded one of the world’s largest lung transplant programs. His team performs over 100 lung transplants each year. In 2018, Dr. Klepetko led the team that performed Niki Lauda’s lung transplant. He is a former president of the European Association for Cardio-Thoracic Surgery. He also serves on the board of the American Association for Thoracic Surgery.

Dr. Klepetko has received the Grand Decoration of Honor for services to the Austrian Republic. He was also awarded the City of Vienna Prize for Medical Sciences for his medical and scientific contributions.